4D Molecular Therapeutics FDMT
NASDAQ FDMT
$13.84 -0.47 (-3.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

4D Molecular Therapeutics (FDMT) Long-Term Investments (2021 - 2026)

Updated

4D Molecular Therapeutics (FDMT) recorded Long-Term Investments of $69.3 million in Q2 2026, down 44.0% from $123.81 million a year earlier but up 3.8% from the prior quarter.

Analysis

4D Molecular Therapeutics (FDMT) Long-Term Investments (2021 - 2026) Analysis & Trends

At the end of FY2025, 4D Molecular Therapeutics reported Long-Term Investments of $111.38 million, up 38.2% from FY2024.

  • Annual Long-Term Investments has increased for three straight years, with a four-year compound annual growth rate of 13.3% (FY2021 to FY2025).
  • Across earlier years, Long-Term Investments came in at $80.58 million in FY2024 (+635.6%), $10.95 million in FY2023 (+123.2%), $4.91 million in FY2022 (-92.7%) and $67.65 million in FY2021.
  • Quarterly Long-Term Investments has ranged from $1.41 million in Q1 2023 to $137 million in Q1 2025 over the past five years.
  • On a year-over-year basis, Long-Term Investments rose in five of the last seven quarters, with growth averaging 140.1%.
  • Peak year-over-year performance for Long-Term Investments in the last five years was growth of 635.6% in Q4 2024, against a decline of 97.1% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $66.74 million (Q1 2026), $111.38 million (Q4 2025) and $67.17 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 4D Molecular Therapeutics 1.01 Bn -454.35 Mn - 69.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.30 Mn
Mar 31, 2026 66.74 Mn
Dec 31, 2025 111.38 Mn
Sep 30, 2025 67.17 Mn
Jun 30, 2025 123.81 Mn
Mar 31, 2025 137.00 Mn
Dec 31, 2024 80.58 Mn
Sep 30, 2024 48.78 Mn
Jun 30, 2024 35.72 Mn
Mar 31, 2024 62.94 Mn
Dec 31, 2023 10.95 Mn
Mar 31, 2023 1.41 Mn
Dec 31, 2022 4.91 Mn
Sep 30, 2022 11.12 Mn
Jun 30, 2022 20.53 Mn
Mar 31, 2022 48.36 Mn
Dec 31, 2021 67.65 Mn
Sep 30, 2021 65.49 Mn
API Access

4D Molecular Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=FDMT&period=max&api_key=YOUR_API_KEY